Institutional Investors Increase Holdings in Amgen Stock
What happened
During the third quarter, multiple institutional investors purchased or increased their holdings in Amgen stock. Bath Savings Trust Co grew its position by 2,509.6%, now owning 23,147 shares valued at $9,757,000. Other firms included Canandaigua National Trust Co, which acquired 2,093 shares, and Worth Asset Management LLC, which bought a stake valued at $1,407,000.
From dailypolitical.com
Why it matters
The activity reflects increased interest from institutional investors in the medical research company. Currently, 76.50% of Amgen stock is owned by hedge funds and other institutional investors, making these transactions significant for market valuation.
From dailypolitical.com
Who's involved
- AmgenAmerican multinational biopharmaceutical company subject to the buying activity
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- AmgenSpeculative
The market price of Amgen stock might change due to the institutional buying and selling activity.
Keep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company